2Fadini Gp,Rattazzi M,Matsumoto T,et al.Emerging role of circulating calcifying cells in the bone-vascular axis[J].Circulation,2012,125(22):2772-2781.
3Derwall M,Malhotra R,Lai CS,et al.Inhibition of bone morphogenetic Protein signaling reduces vascular calcification and atherosclerosis[J].AeterioscerTheomb Vaasc Biol,2012,32(3):613-622.
4Chen NX,Kircelli F,0,Neill KD,et al.Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells[J].Kidney Int,2010,77(5):436-442.
5Liu KH,Chu WC,Kong AP,et al.US assessment of medial arterial calci- fication:a sensitive marker of diabetes-related microvascular and macro- vascular complications[J].Radiology,2012,265(1):294-302.
6Marinelli A,Pistolesi V,Pasquale L,et al.Diagnosis of arterial media cal- cification in chronic kidney discase[J].Cardiorenal Med,2013,3(2);89-95.
7Armstrong ZB,Boughner DR,Drangova M,et al.Angiotensin II type I receptor blocker inhibits arterial calcification in a pre-clinical model[J].Cardiovasc Res,2011,90(1):165-170.
8Wu SY,Yu YR,Cai Y,et al.Endogenous aldosterone is involved in vas- cular calcification in rat[J].Exp Biol Med(Maywood),2012,237(1):31-37.
9Chen NX,Duan D,O'Neill DK,et al.High glucose the expression of Cbfal and BMP-2 and enhances the calcification of vascular smooth muscle cells[J].Nephrol Dial Transplant,2006,21(12):3435-3442.
10Bostrom KI,Jumabay M,Matveyenko A,et al.Activation of vascular bone morphogenetic protein signaling in diabetes mellitus[J].Circ Res,2011,108(4):446-457.
二级参考文献92
1Chobanian A V, Bakris G L, Black H R, et al. Seventh report of the joint national committee on prevention, detection evaluation, and treatment of high blood pressure [ J ]. Hypertension,2003,42 (6) :1206 - 1252.
2Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2003,26 (Suppl) :5220.
3Borden W B, Davidson M H. Updating the assessment of cardiac risk: beyond Framingham [ J ]. Rev Cardiovasc Med, 2009, 10 (2) :63 - 71.
4Gertler M M, Garn S M, Levine S A. Serum uric acid in relation to age and physique in health and coronary heart disease [ J ]. Ann Intern Med,1951,34(6) :1421 - 1431.
5Jelic - IvanovicZ, Memon L,Spasojevic'- Kalimanovska V,et al. Independent association of high serum uric acid concentration with angiographically defined coronary artery disease[ J ]. Tohoku J Exp Med,2007,211 (4) :369 - 377.
6Behague I,Poiriem,Nicaud V,et al. Beta fibrinogen gene polymorphisms are associaled with plasma fibrinogen and coronary artery disease in patientswith plasrm fibrinogen mad coronary artery disease in patients with myocardial infarction. The ECTIM Study[J]. Circulation,2(134,93(3) : 440-440.
7Naglaa K l,Andrew D B,Gregory Y H L,et al. Hemoxygenase - 1 in cardiovascular disease[ J]. JACC ,2008,52(12) :971 - 978.
8Endler G,Klimesch A,Suncler Plassmann H,et al. Mean platelet vo - lume is an independent risk factor for myocardial infarction but not for coronary disease [ J ]. Br J Haemasro1,2005 ,117 (2) :399 - 404.
